Skip to main content
NIH funding notice RFA-DA-25-012

Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)

Closed on October 28, 2024.

Posted
October 17, 2023
Close date
October 28, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,114,152 in first-year total cost, median $740,880.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 SXC-N (O1)]7

Most frequent institutions

  1. UNIVERSITY OF NEBRASKA MEDICAL CENTER2
  2. BOSTON UNIVERSITY MEDICAL CAMPUS1
  3. EMORY UNIVERSITY1
  4. MEDICAL UNIVERSITY OF SOUTH CAROLINA1
  5. STATE UNIVERSITY NEW YORK STONY BROOK1
Competing awards under RFA-DA-25-012 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis1R01DA059874-01A1BYRAREDDY, SIDDAPPA NMOHAN, MAHESHUNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$898,025ZDA1
2025Disentangling the HIV/opioid intertwined mechanisms on mitochondrial mediated inflammasome activation, neurotoxicity and targeting strategies: In vivo and in vitro analyses of fresh human brain1R01DA062278-01CHAILLON, ANTOINEFIELDS, JEREL ADAMUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$794,203ZDA1
2025Molecular interplay of HIV Tat, cocaine, and cART in microglial pyroptosis: Role of NLRP3 inflammasome1R01DA062274-01BUCH, SHILPA JPERIYASAMY, PALSAMYUNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$490,172ZDA1
2024Mechanisms of Persistent Inflammasome Activation in Myeloid Cells1R01DA059952-01A1GUMMULURU, SURYARAMHENDERSON, ANDREW JBOSTON UNIVERSITY MEDICAL CAMPUS, MA$777,398ZDA1
2024Methamphetamine Activation of Inflammasome and Altered immunity in HIV (MAIA) Study1R01DA062380-01LEE, SULGGI ANGELAPEREIRA RIBEIRO, SUSANEMORY UNIVERSITY, GA$740,880ZDA1
2024The spinal cell atlas of opioid-targeted inflammasomes in the HIV pain model: mechanism and pathogenic role1R01DA062257-01TANG, SHAO-JUNSTATE UNIVERSITY NEW YORK STONY BROOK, NY$708,397ZDA1
2024Impacts of drug abuse-mediated inflammatory perturbations on affinity maturation of anti-CD4 autoantibodies and poor immune reconstitution from ART in HIV1R01DA059854-01A1JIANG, WEISHENG, ZIZHANGMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$705,077ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-25-012: Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience